00460 SIHUAN PHARM
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 1.80X | Oper Margin | 23.2% |
|---|---|---|---|
| LT Debt/Equity | 12.0% | Net Margin | 6.9% |
| Total Debt/Equity | 15.6% | Return on Equity | 3.1% |
| Price/Book | 1.98X | Return on Assets | 1.5% |
| (HKD 1.410) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 200.02 | -230.42 | -59.54 | -2,147.01 | 509.43 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +186.8 | -287.0 | +97.2 | -521.5 | -9.3 |
| Earnings Per Share (HKD) | 0.022 | -0.025 | -0.006 | -0.23 | 0.054 |
| Earnings Per Share Growth (%) | +188.0 | -289.1 | +97.2 | -526.1 | -9.1 |
| Dividend Per Share (HKD) | 0.022 | 0.021 | No dividend | 0.073 | 0.133 |
| P/E* (X) | 64.38 | N/A | N/A | N/A | 26.11 |
| Yield (%) | 1.53 | 1.49 | N/A | 5.17 | 9.43 |
| Dividend Share (%) | 98.63 | N/A | N/A | N/A | 246.30 |
| Book NAV (HKD) | 0.712 | 0.500 | 0.524 | 0.569 | 1.086 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 2,618 | 1,901 | +37.7 | 1,861 |
| Operating Result | 405.549 | -473.858 | -185.6 | -136.963 |
| Associates | 11.607 | -15.226 | -176.2 | -53.621 |
| Profit Before Taxation | 417.156 | -428.288 | -197.4 | -161.26 |
| Taxation | 231.752 | 43.261 | +435.7 | 96.427 |
| Profit /( Loss) After Taxation | 185.404 | -471.549 | -139.3 | -257.687 |
| Minority Interests | 5.708 | -254.887 | -102.2 | -203.67 |
| Net Profit | 179.696 | -216.662 | -182.9 | -54.017 |
| Earnings Per Share () | 0.0219 | -0.0249 | -188.0 | -0.0064 |
| Dividend Per Share () | 0.0216 | 0.0210 | +2.9 | 0.0000 |
| Announcement Date | 2026-03-31 | 2025-03-28 | NA | 2024-03-28 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
